SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-009495
Filing Date
2015-11-05
Accepted
2015-11-05 07:01:51
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q srpt-10q_20150930.htm 10-Q 2244835
2 EX-31.1 srpt-ex311_8.htm EX-31.1 10568
3 EX-31.2 srpt-ex312_9.htm EX-31.2 10640
4 EX-32.1 srpt-ex321_10.htm EX-32.1 7315
5 EX-32.2 srpt-ex322_11.htm EX-32.2 7337
  Complete submission text file 0001564590-15-009495.txt   6151251

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srpt-20150930.xml EX-101.INS 1275622
7 XBRL TAXONOMY EXTENSION SCHEMA srpt-20150930.xsd EX-101.SCH 33393
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20150930_cal.xml EX-101.CAL 43183
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20150930_def.xml EX-101.DEF 80119
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20150930_lab.xml EX-101.LAB 244641
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20150930_pre.xml EX-101.PRE 197837
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 151198733
SIC: 2834 Pharmaceutical Preparations